Harold Alfond Center For Cancer is categorized under in Augusta, ME and active since 2008.
Harold Alfond Center For Cancer was established in 2008, and today employs 1 to 4, earning $2.500.000 to $4.999.999 per year. This is a business, which does work in the B2B market, and is classified as a , under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Arlene Mclean, Office Manager at the company’s single location by writing to 361 Old Belgrade Road, Augusta, Maine ME 04330 or by phoning (207) 621-6100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Harold Alfond Center For Cancer |
| Contact Person: | Arlene Mclean, Office Manager |
| Address: | 361 Old Belgrade Road, Augusta, Maine 04330 |
| Phone Number: | (207) 621-6100 |
| Website Address: | mainegeneral.org |
| Annual Revenue (USD): | $2.500.000 to $4.999.999 |
| Founded: | 2008 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | |
| SIC Code: | 8031 |
| NAICS Code: | 6211110 |
| Share This Business: |
Harold Alfond Center For Cancer was started in 2008 to provide professional under the SIC code 8031 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $2.500.000 to $4.999.999 per annum.
Feel free to contact Arlene Mclean, Office Manager for inquiries that concern Harold Alfond Center For Cancer by calling the company number (207) 621-6100, as your correspondence is most welcome. Additionally, the physical location of the single location of Harold Alfond Center For Cancer can be found at the coordinates 44.36194,-69.78631 as well as the street address 361 Old Belgrade Road in Augusta, Maine 04330.
For its online presence, you may visit Harold Alfond Center For Cancer’s website at mainegeneral.org and engage with its social media outlets through on Twitter and on Facebook.